Myxoid stroma is associated with postoperative relapse in patients with stage II colon cancer.
Takashi OkuyamaShinichi SameshimaEmiko TakeshitaTakashi MitsuiTakuji NoroYuko OnoTamaki NoieShinichi BanMasatoshi OyaPublished in: BMC cancer (2020)
The present study suggests that MY is a predictive marker for postoperative relapse in patients with stage II colon cancer.
Keyphrases